Stay updated on Masitinib Efficacy and Safety in ALS Clinical Trial
Sign up to get notified when there's something new on the Masitinib Efficacy and Safety in ALS Clinical Trial page.

Latest updates to the Masitinib Efficacy and Safety in ALS Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a new Locations section with site listings for Alabama, California, Kentucky, Maryland, Massachusetts, Virginia, and Modena, and updated the revision to v3.3.3. The previous individual location subsections (e.g., Alabama Locations, California Locations, Modena Locations) have been removed.SummaryDifference0.5%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedPublications section wording updated to indicate that publications are automatically filled from PubMed, and the revision banner now shows v3.3.2 (previously v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedThe banner about government funding and operating status was removed from the page.SummaryDifference0.2%

- Check62 days agoChange DetectedCosmetic UI and layout updates observed on the Study Details page for NCT03127267; core study data including eligibility, primary outcomes, and enrollment remains unchanged.SummaryDifference0.3%

- Check91 days agoChange DetectedUpdated to v3.2.0 and added a government funding/operating-status notice; removed the old v3.1.0 reference.SummaryDifference3%

- Check98 days agoChange DetectedUpdate to version v3.1.0 with an added contact number; several safety/topic keywords removed (potential scope shift in content).SummaryDifference0.4%

Stay in the know with updates to Masitinib Efficacy and Safety in ALS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Masitinib Efficacy and Safety in ALS Clinical Trial page.